Cefepime-induced neurotoxicity in a patient with renal dysfunction: a case report
Cefepime is an antimicrobial widely used in the hospital environment. During the development phases, the drug proved to be safe and, therefore, was approved and marketed. After the commercialization of cefepime, case reports involving a serious adverse reaction were emerging. Cefepime-Induced Neurot...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2023-03-01
|
| Series: | Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde |
| Online Access: | https://rbfhss.org.br/sbrafh/article/view/917 |
| _version_ | 1797855385208487936 |
|---|---|
| author | Daniela V. SILVA Cleni VERONEZE Priscila L. GUIMARÃES |
| author_facet | Daniela V. SILVA Cleni VERONEZE Priscila L. GUIMARÃES |
| author_sort | Daniela V. SILVA |
| collection | DOAJ |
| description | Cefepime is an antimicrobial widely used in the hospital environment. During the development phases, the drug proved to be safe and, therefore, was approved and marketed. After the commercialization of cefepime, case reports involving a serious adverse reaction were emerging. Cefepime-Induced Neurotoxicity (CIN) is a reaction that occurs most often in patients with renal dysfunction, damage to the blood-brain barrier or advanced age. Dose adjustment should be made according to creatinine clearance in order to prevent adverse reaction. Among the symptoms are drowsiness, tremors, myoclonus, agitation, lowered level of consciousness, convulsions and coma. The electroencephalogram can be used to aid in the diagnosis, but it is not specific for this condition. In this article, we present a case report of a 52-year-old woman with acute renal failure who presented CIN after using cefepime, despite dose adjustments according to renal function. The patient presented the symptoms even after discontinuing the medication and hemodialysis did not reverse the condition. The patient’s physiological characteristics may have contributed to the outcome of the case. The description of CIN cases in the literature is important for a better understanding of the pathophysiology that involves the adverse reaction and prevention of new cases. |
| first_indexed | 2024-04-09T20:22:52Z |
| format | Article |
| id | doaj.art-1e9ae9318cd9432b98fc6ab2259fa8cb |
| institution | Directory Open Access Journal |
| issn | 2179-5924 2316-7750 |
| language | English |
| last_indexed | 2024-04-09T20:22:52Z |
| publishDate | 2023-03-01 |
| publisher | Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde |
| record_format | Article |
| series | Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde |
| spelling | doaj.art-1e9ae9318cd9432b98fc6ab2259fa8cb2023-03-30T20:33:31ZengSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdeRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde2179-59242316-77502023-03-0114191791710.30968/rbfhss.2023.141.09171300Cefepime-induced neurotoxicity in a patient with renal dysfunction: a case reportDaniela V. SILVAhttps://orcid.org/0000-0003-1034-5259Cleni VERONEZEhttps://orcid.org/0000-0002-0905-4887Priscila L. GUIMARÃEShttps://orcid.org/0000-0003-3824-0862Cefepime is an antimicrobial widely used in the hospital environment. During the development phases, the drug proved to be safe and, therefore, was approved and marketed. After the commercialization of cefepime, case reports involving a serious adverse reaction were emerging. Cefepime-Induced Neurotoxicity (CIN) is a reaction that occurs most often in patients with renal dysfunction, damage to the blood-brain barrier or advanced age. Dose adjustment should be made according to creatinine clearance in order to prevent adverse reaction. Among the symptoms are drowsiness, tremors, myoclonus, agitation, lowered level of consciousness, convulsions and coma. The electroencephalogram can be used to aid in the diagnosis, but it is not specific for this condition. In this article, we present a case report of a 52-year-old woman with acute renal failure who presented CIN after using cefepime, despite dose adjustments according to renal function. The patient presented the symptoms even after discontinuing the medication and hemodialysis did not reverse the condition. The patient’s physiological characteristics may have contributed to the outcome of the case. The description of CIN cases in the literature is important for a better understanding of the pathophysiology that involves the adverse reaction and prevention of new cases.https://rbfhss.org.br/sbrafh/article/view/917 |
| spellingShingle | Daniela V. SILVA Cleni VERONEZE Priscila L. GUIMARÃES Cefepime-induced neurotoxicity in a patient with renal dysfunction: a case report Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde |
| title | Cefepime-induced neurotoxicity in a patient with renal dysfunction: a case report |
| title_full | Cefepime-induced neurotoxicity in a patient with renal dysfunction: a case report |
| title_fullStr | Cefepime-induced neurotoxicity in a patient with renal dysfunction: a case report |
| title_full_unstemmed | Cefepime-induced neurotoxicity in a patient with renal dysfunction: a case report |
| title_short | Cefepime-induced neurotoxicity in a patient with renal dysfunction: a case report |
| title_sort | cefepime induced neurotoxicity in a patient with renal dysfunction a case report |
| url | https://rbfhss.org.br/sbrafh/article/view/917 |
| work_keys_str_mv | AT danielavsilva cefepimeinducedneurotoxicityinapatientwithrenaldysfunctionacasereport AT cleniveroneze cefepimeinducedneurotoxicityinapatientwithrenaldysfunctionacasereport AT priscilalguimaraes cefepimeinducedneurotoxicityinapatientwithrenaldysfunctionacasereport |